MRNA PP&E Net History: $209.5M (FY2019)

Fiscal year	Q1	Q2	Q3	Q4
FY20	$213M	$209M	$204M	Not reported
FY18	Not reported	Not reported	Not reported	$212M+52.5%
FY17	Not reported	Not reported	Not reported	$139M

01—History

PP&E Net History

Year-over-year comparison from 10-K annual reports · Dashed line: constant growth FY2017–FY2019. Drag across the bars to change the range.

$209.5M

YoY changeLargest recent move+52.5%in FY18Latest −1.2%

02—Ledger

PP&E Net, period by period

Period	Value	Change	Source
FY2019	$209.5M	−1.2%	10-K
FY2018	$212.0M	+52.5%	10-K
FY2017	$139.0M	—	10-K

03—Questions

What is Moderna, Inc.'s current pp&e net?

Moderna, Inc. (MRNA) annual pp&e net for 2019 was $209.5M, a 1.17% decline from 2018. Moderna, Inc. pp&e net for the quarter ending January 1, 2019 was $209.5M.

What was Moderna, Inc.'s pp&e net in 2018?

Moderna, Inc. annual pp&e net for 2018 was $212.0M, a 52.47% increase from 2017.

What was Moderna, Inc.'s pp&e net in 2017?

Moderna, Inc. annual pp&e net for 2017 was $139.0M.

What is Moderna, Inc.'s 2-year pp&e net CAGR?

Moderna, Inc. pp&e net grew at a compound annual growth rate (CAGR) of 22.75% from FY2017 to FY2019, going from $139.0M to $209.5M over 2 years.

Company: Moderna, Inc.
Ticker: MRNA
Sector: Healthcare
Industry: Biological Products, (No Diagnostic Substances)

Moderna, Inc. PP&E Net 2017-2019 | MRNA

Key Statistics